More Than Medicine

Welcome to Novo Nordisk’s Scientific Exchange. Designed to foster the exchange of scientific information, the site provides access to educational information about Novo Nordisk’s medicines, therapeutic areas of interest, and congress activities. All content is intended for use by U.S. Healthcare Professionals only.

Explore content by therapeutic area

Explore content by therapeutic area

Diabetes
Obesity
Liver Health
Cardiovascular Disease
Rare Bleeding Disorders
Rare Endocrine Disorders
Rare Renal Disorders
Hemoglobinopathies

SELECT: cardiovascular outcome trial in obesity

The SELECT trial evaluated the effect of semaglutide 2.4 mg once weekly on cardiovascular outcomes in patients with overweight or obesity and cardiovascular disease.

Discover more

Find product information

Survey Novo Nordisk’s portfolio of products and resources for the treatment of diabetes, obesity, liver health, and cardiovascular disease and treatments for rare bleeding, rare endocrine, and rare renal disorders.

View products

Continuing education

Learn about accredited CE activities developed by third-party providers and supported by Novo Nordisk via independent medical education grants.

Explore CE

Find more information

Speak to a medical representative

If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.

Submit a question

Search the Medical Information Database

The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.

Begin search

Top

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.